Livzon News_Livzon Pharmaceutical Group Inc.

News Center

New Lijuzhu Magazine

Lizhu Group won the first Charity Model Award in Zhuhai City.

Lizhu Group won the first Charity Model Award in Zhuhai City.

2022-01-05

Set sail! Lijun PD-1 has reached an overseas licensing cooperation with Bright Peak.

Set sail! Lijun PD-1 has reached an overseas licensing cooperation with Bright Peak.

2021-12-13

Look! Our product is on the award list!

Look! Our product is on the award list!

2021-12-13

The Russian Ministry of Health has approved the restructuring of the Lijun Group's novel coronavirus fusion protein vaccine to conduct phase III clinical research.

The Russian Ministry of Health has approved the restructuring of the Lijun Group's novel coronavirus fusion protein vaccine to conduct phase III clinical research.

On November 8, the Russian Ministry of Health announced on the National Research License Registration website that it has issued a license approving the "Recombinant Novel Coronavirus Fusion Protein Vaccine" (V-01) developed by Livzon Mabpharm Inc. in Zhuhai, China, to conduct Phase III clinical research. This involves a "randomized, double-blind, placebo-controlled, international multicenter Phase III clinical trial to evaluate the efficacy, safety, and immunogenicity of the recombinant novel coronavirus (SARS-CoV-2) fusion protein vaccine (V-01) in adults aged 18 and older."

2021-11-12

Congratulations to Dr. Cao Hui on being elected as a foreign academician of the Russian Academy of Sciences.

Congratulations to Dr. Cao Hui on being elected as a foreign academician of the Russian Academy of Sciences.

2021-08-12

Lizhu Pharmaceutical Group, Health Yuan Pharmaceutical Group, and Zhihua Technology have initiated a strategic partnership to collaboratively advance the application of AI in process chemistry.

Lizhu Pharmaceutical Group, Health Yuan Pharmaceutical Group, and Zhihua Technology have initiated a strategic partnership to collaboratively advance the application of AI in process chemistry.

2021-08-03

Jian Kang Yuan & Li Zhu Group donated 20 million to support Henan.

Jian Kang Yuan & Li Zhu Group donated 20 million to support Henan.

2021-07-23

Statement regarding criminals impersonating our company to engage in fraudulent activities.

Statement regarding criminals impersonating our company to engage in fraudulent activities.

2021-05-24

< 1...4 5 6...22 > proceed page

Address: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China

京ICP备10002622号

Website :www.300.cn SEO [ Privacy Policy ]

Internet Drug Information Service Qualification Certificate: Guangdong-Non-Operating -2020-0186

Drug Business License: Guangdong AA7560155

Business License

Home | E-mail | Legal Statement

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.